Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Pipeline Insight: Hematological Malignancies ' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Global Pipeline Review & Analysis of Hematological Malignancies | Mar 2007 | £1,960 | 100% |
| Hematological Cancers - A Therapeutic & Competitive Insight | Oct 2006 | £2,450 | 98% |
| Stem Cell-Based Therapeutic Delivery Challenges & Opportunities |
Dec 2008 | £945 | 88% |
| Stakeholder Insight: Supportive Care in Cancer Treatment Some first-generation products proving difficult to dislodge |
Oct 2006 | £8,365 | 85% |
| Pipeline Insight: Therapeutic Cancer Vaccines Prospect of first approval set to reinvigorate interest from major companies |
Dec 2009 | £7,210 | 63% |
| Pipeline Insight: Cancer Overview Gastrointestinal, Skin, Sarcomas |
Jan 2009 | £7,210 | 62% |
| Genzyme Corporation Product Pipeline Analysis | Aug 2008 | £475 | 62% |
| Pipeline Insight: Breast Cancer Recent approvals increase pressure on pipeline candidates |
Apr 2008 | £7,210 | 52% |
- Results 1 - 8 of 8
-
-
- 1
-
-
